medigraphic.com
SPANISH

Revista Mexicana de Cardiología

ISSN 0188-2198 (Print)
En 2019, la Revista Mexicana de Cardiología cambió a Cardiovascular and Metabolic Science

Ver Cardiovascular and Metabolic Science


  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 3

Next >>

Rev Mex Cardiol 2008; 19 (3)

Transcatheter closure of atrial septal defect with Amplatzer device. Experience in the Clinical Cardiovascular Santamaría

Guzmán BMI, Díaz LH, Lince VR, Ruz MM
Full text How to cite this article

Language: Spanish
References: 0
Page: 115-119
PDF size: 111.62 Kb.


Key words:

Atrial septal defect (ASD), transcatheter closure, Amplatzer.

ABSTRACT

Introduction: The defects septum interatrial are congenital abnormalities characteristic which is a structural weakness of the interauricular septum. It comes with a frequency of 10% of congenital heart disease, being the most frequent if we exclude the aorta bivalva and mitral valve prolapse. The Transcatheter closure of Atrial Septal Defect (ASD) with Amplatzer device is an effective procedure, low morbidity and offered good results for the patient. Objectives: Take a retrospective analysis of patients with a diagnosis of ASD who were treated with Transcatheter closure with Amplatzer device. Material and methods: During the period between January 2004 and September 2007 in the Clinical Cardiovascular Santamaria, were taken to the Hemodynamic laboratory 51 patients with diagnosis ASD to attempt to Transcatheter closure. There was confirmation of diagnosis and proceeded to close the defect. Results: Age average 7.49 years, 70.5% women and 29.5% men. Size of the ASD half measured by echocardiography was: 16.9 (8-30). The QP / QS medium: 1.99 by echocardiography and 1.76 per angiography. The fluoroscopy averaged Time: 14.8 minutes and 65.55 minutes catheterization. It successfully implants the device in a 94.1% staff study without complications occur. Only one patient presenting with residual leakage, but this problem was resolution within 24 hours. Conclusions: The transcatheter closure of ASD with Amplatzer device type is a safe procedure for the patient with good results and low morbidity.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Cardiol. 2008;19